Increased prevalence of inflammatory bowel disease in patients with mutations in genes encoding the receptor subunits for TGFb

Anthony L Guerrerio, Pamela A. Frischmeyer-Guerrerio, Chengrui Huang, Yuqiong Wu, Talin Haritunians, Dermot P B McGovern, Gretchen L. MacCarrick, Steven R. Brant, Harry C Dietz

Research output: Contribution to journalArticle

Abstract

Background: TGFβ is a multifunctional cytokine that is critical in regulating mucosal immunity. Murine studies have revealed that disruption of canonical TGFβ signaling leads to systemic inflammation including colitis. Loeys-Dietz syndrome (LDS) results from heterozygous mutations in the genes encoding the subunits of the TGFβ receptor. Methods: All patients with confirmed mutations in TGFBR1 or TGFBR2, seen in the Johns Hopkins Connective Tissue Disorders clinic, were asked to participate in the study. Ninety-three consecutive patients were enrolled, including 4 with inflammatory bowel disease (IBD). Using the Illumina Immunochip array, we undertook an exploratory analysis to evaluate the potential genetic risk factors that could predict which patients with LDS would develop IBD. Results: We report an increased prevalence of IBD in patients with LDS types I and II. We describe the course of several patients. In this small sample, the 3 whites with IBD had a genetic risk score in the top 6 highest scores of patients evaluated. Conclusion: We report a 10-fold increase in the prevalence of IBD in patients with LDS compared with the general population. Onset of disease in 3 of the 4 patients was at less than 18 years, and the clinical course in 2 of the 4 was severe with a poor response to traditional medications. Further evaluation of the genetic risk score is needed to determine whether it can predict which patients with LDS are most likely to develop IBD. This case series of patients with LDS with IBD suggests that defective TGFβ signaling may have an influence on IBD risk.

Original languageEnglish (US)
Pages (from-to)2058-2062
Number of pages5
JournalInflammatory Bowel Diseases
Volume22
Issue number9
DOIs
StatePublished - Aug 10 2016

Fingerprint

Loeys-Dietz Syndrome
Inflammatory Bowel Diseases
Mutation
Genes
Mucosal Immunity
Colitis
Connective Tissue
Cytokines
Inflammation

Keywords

  • genetic predisposition
  • Loeys-Dietz syndrome
  • pediatric
  • syndromes associated with IBD
  • TGFβ receptor
  • very early-onset IBD

ASJC Scopus subject areas

  • Immunology and Allergy
  • Medicine(all)
  • Gastroenterology

Cite this

Increased prevalence of inflammatory bowel disease in patients with mutations in genes encoding the receptor subunits for TGFb. / Guerrerio, Anthony L; Frischmeyer-Guerrerio, Pamela A.; Huang, Chengrui; Wu, Yuqiong; Haritunians, Talin; McGovern, Dermot P B; MacCarrick, Gretchen L.; Brant, Steven R.; Dietz, Harry C.

In: Inflammatory Bowel Diseases, Vol. 22, No. 9, 10.08.2016, p. 2058-2062.

Research output: Contribution to journalArticle

Guerrerio, Anthony L ; Frischmeyer-Guerrerio, Pamela A. ; Huang, Chengrui ; Wu, Yuqiong ; Haritunians, Talin ; McGovern, Dermot P B ; MacCarrick, Gretchen L. ; Brant, Steven R. ; Dietz, Harry C. / Increased prevalence of inflammatory bowel disease in patients with mutations in genes encoding the receptor subunits for TGFb. In: Inflammatory Bowel Diseases. 2016 ; Vol. 22, No. 9. pp. 2058-2062.
@article{8f7c30fb725748869d5ed3b758155f04,
title = "Increased prevalence of inflammatory bowel disease in patients with mutations in genes encoding the receptor subunits for TGFb",
abstract = "Background: TGFβ is a multifunctional cytokine that is critical in regulating mucosal immunity. Murine studies have revealed that disruption of canonical TGFβ signaling leads to systemic inflammation including colitis. Loeys-Dietz syndrome (LDS) results from heterozygous mutations in the genes encoding the subunits of the TGFβ receptor. Methods: All patients with confirmed mutations in TGFBR1 or TGFBR2, seen in the Johns Hopkins Connective Tissue Disorders clinic, were asked to participate in the study. Ninety-three consecutive patients were enrolled, including 4 with inflammatory bowel disease (IBD). Using the Illumina Immunochip array, we undertook an exploratory analysis to evaluate the potential genetic risk factors that could predict which patients with LDS would develop IBD. Results: We report an increased prevalence of IBD in patients with LDS types I and II. We describe the course of several patients. In this small sample, the 3 whites with IBD had a genetic risk score in the top 6 highest scores of patients evaluated. Conclusion: We report a 10-fold increase in the prevalence of IBD in patients with LDS compared with the general population. Onset of disease in 3 of the 4 patients was at less than 18 years, and the clinical course in 2 of the 4 was severe with a poor response to traditional medications. Further evaluation of the genetic risk score is needed to determine whether it can predict which patients with LDS are most likely to develop IBD. This case series of patients with LDS with IBD suggests that defective TGFβ signaling may have an influence on IBD risk.",
keywords = "genetic predisposition, Loeys-Dietz syndrome, pediatric, syndromes associated with IBD, TGFβ receptor, very early-onset IBD",
author = "Guerrerio, {Anthony L} and Frischmeyer-Guerrerio, {Pamela A.} and Chengrui Huang and Yuqiong Wu and Talin Haritunians and McGovern, {Dermot P B} and MacCarrick, {Gretchen L.} and Brant, {Steven R.} and Dietz, {Harry C}",
year = "2016",
month = "8",
day = "10",
doi = "10.1097/MIB.0000000000000872",
language = "English (US)",
volume = "22",
pages = "2058--2062",
journal = "Inflammatory Bowel Diseases",
issn = "1078-0998",
publisher = "John Wiley and Sons Inc.",
number = "9",

}

TY - JOUR

T1 - Increased prevalence of inflammatory bowel disease in patients with mutations in genes encoding the receptor subunits for TGFb

AU - Guerrerio, Anthony L

AU - Frischmeyer-Guerrerio, Pamela A.

AU - Huang, Chengrui

AU - Wu, Yuqiong

AU - Haritunians, Talin

AU - McGovern, Dermot P B

AU - MacCarrick, Gretchen L.

AU - Brant, Steven R.

AU - Dietz, Harry C

PY - 2016/8/10

Y1 - 2016/8/10

N2 - Background: TGFβ is a multifunctional cytokine that is critical in regulating mucosal immunity. Murine studies have revealed that disruption of canonical TGFβ signaling leads to systemic inflammation including colitis. Loeys-Dietz syndrome (LDS) results from heterozygous mutations in the genes encoding the subunits of the TGFβ receptor. Methods: All patients with confirmed mutations in TGFBR1 or TGFBR2, seen in the Johns Hopkins Connective Tissue Disorders clinic, were asked to participate in the study. Ninety-three consecutive patients were enrolled, including 4 with inflammatory bowel disease (IBD). Using the Illumina Immunochip array, we undertook an exploratory analysis to evaluate the potential genetic risk factors that could predict which patients with LDS would develop IBD. Results: We report an increased prevalence of IBD in patients with LDS types I and II. We describe the course of several patients. In this small sample, the 3 whites with IBD had a genetic risk score in the top 6 highest scores of patients evaluated. Conclusion: We report a 10-fold increase in the prevalence of IBD in patients with LDS compared with the general population. Onset of disease in 3 of the 4 patients was at less than 18 years, and the clinical course in 2 of the 4 was severe with a poor response to traditional medications. Further evaluation of the genetic risk score is needed to determine whether it can predict which patients with LDS are most likely to develop IBD. This case series of patients with LDS with IBD suggests that defective TGFβ signaling may have an influence on IBD risk.

AB - Background: TGFβ is a multifunctional cytokine that is critical in regulating mucosal immunity. Murine studies have revealed that disruption of canonical TGFβ signaling leads to systemic inflammation including colitis. Loeys-Dietz syndrome (LDS) results from heterozygous mutations in the genes encoding the subunits of the TGFβ receptor. Methods: All patients with confirmed mutations in TGFBR1 or TGFBR2, seen in the Johns Hopkins Connective Tissue Disorders clinic, were asked to participate in the study. Ninety-three consecutive patients were enrolled, including 4 with inflammatory bowel disease (IBD). Using the Illumina Immunochip array, we undertook an exploratory analysis to evaluate the potential genetic risk factors that could predict which patients with LDS would develop IBD. Results: We report an increased prevalence of IBD in patients with LDS types I and II. We describe the course of several patients. In this small sample, the 3 whites with IBD had a genetic risk score in the top 6 highest scores of patients evaluated. Conclusion: We report a 10-fold increase in the prevalence of IBD in patients with LDS compared with the general population. Onset of disease in 3 of the 4 patients was at less than 18 years, and the clinical course in 2 of the 4 was severe with a poor response to traditional medications. Further evaluation of the genetic risk score is needed to determine whether it can predict which patients with LDS are most likely to develop IBD. This case series of patients with LDS with IBD suggests that defective TGFβ signaling may have an influence on IBD risk.

KW - genetic predisposition

KW - Loeys-Dietz syndrome

KW - pediatric

KW - syndromes associated with IBD

KW - TGFβ receptor

KW - very early-onset IBD

UR - http://www.scopus.com/inward/record.url?scp=84983680551&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84983680551&partnerID=8YFLogxK

U2 - 10.1097/MIB.0000000000000872

DO - 10.1097/MIB.0000000000000872

M3 - Article

C2 - 27508510

AN - SCOPUS:84983680551

VL - 22

SP - 2058

EP - 2062

JO - Inflammatory Bowel Diseases

JF - Inflammatory Bowel Diseases

SN - 1078-0998

IS - 9

ER -